CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
PetIQ Inc Company Snapshot
PetIQ, Inc. is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield. It distributes the products through veterinarian, retail and e-commerce channels. The Company offers its products in a range of categories, including Rx Medications, OTC Medications and Supplies, and Health and Wellness Products. Rx Medications offering includes heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics and other specialty medications. The Company manufactures Heart Shield Plus, version of Heartgard Plus, which prevents heartworm infection in dogs. The Company also manufactures TruProfen, the version of Rimadyl, which treats arthritis in dogs. OTC Medications and Supplies include flea and tick control products.

Sales Analysis. PetIQ Inc reported sales of $709.43 million for the year ending December of 2019. This represents an increase of 34.2% versus 2018, when the company's sales were $528.61 million. This was the third consecutive year of growth at PetIQ Inc. Sales of Products saw an increase of 37.1% in 2019, from $450.23 million to $617.12 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
PetIQ Inc
  Stock Performance Chart for PetIQ Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (4/3/2020): 20.58
(Figures in U.S. Dollars)
1 Week -4.1%   13 Weeks -27.9%  
4 Weeks -17.9%   52 Weeks -35.3%  
 
PetIQ Inc Key Data:
  Ticker: PETQ Country: United States
  Exchanges: NAS Major Industry: Food, Beverage & Tobacco
    Sub Industry: Dog & Cat Food
  2019 Sales 709,431,000
(Year Ending Jan 2020).
Employees: 1,866
  Currency: U.S. Dollars Market Cap: 582,537,480
  Fiscal Yr Ends: December Shares Outstanding: 28,306,000
  Share Type: COMMON Closely Held Shares: 5,182,235
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.